tnxp (TNXP) Analyst & Key Data

Analyst Consensus

Buy7 analysts

Buy

Updated Sep 12, 2026

Total Analysts7

Buy

6

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score4.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$11.87

DCF Value+105.32%

$24.37

Potential upside vs current price

Current Stock Price

$11.87

DCF Value+105.32%

$24.37

Potential upside vs current price

Analyst Consensus

Buy7 analysts

Buy

Updated Sep 12, 2026

Total Analysts7

Buy

6

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score4.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$11.87

DCF Value+105.32%

$24.37

Potential upside vs current price

Current Stock Price

$11.87

DCF Value+105.32%

$24.37

Potential upside vs current price

Tonix Pharmaceuticals Holding Corp.